These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9344333)

  • 1. Evidence for the viral aetiology of IDDM.
    Petrovsky N; Harrison LC; Kyvik KO; Beck-Nielsen H; Green A; Bonnevie-Nielsen V
    Autoimmunity; 1997; 25(4):251-2. PubMed ID: 9344333
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of elevated levels of 2-5A synthetase in serum from children with various infectious diseases.
    Sugino H; Mitani I; Koike M; Kodama T; Sokawa J; Sawai H; Ishibashi K; Itoh M; Watanabe S; Sokawa Y
    J Clin Microbiol; 1986 Sep; 24(3):478-81. PubMed ID: 3760142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [2' 5'-oligoadenylate synthetase (2-5AS)].
    Kaneko S; Sakai A
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():812-4. PubMed ID: 15658457
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical value of the determination of an interferon-induced enzyme activity: studies of the 2'5' oligoadenylate synthetase activity in peripheral blood lymphocytes of patients.
    Chousterman S; Chousterman M; Reinert P; Thang MN
    Biomed Pharmacother; 1983; 37(4):176-80. PubMed ID: 6198003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [2-5 Oligoadenylate synthetase].
    Koura T; Kato Y; Unoura M
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():202-5. PubMed ID: 8753217
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence from twins for acquired cellular immune hyperactivity in type 1 diabetes.
    Petrovsky N; Kyvik KO; Bonnevie-Nielsen V; Beck-Nielsen H; Green A; Harrison LC
    Immunology; 2002 Aug; 106(4):584-9. PubMed ID: 12153522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activity of 2, 5-oligoadenylate synthetase in non-A, non-B hepatitis].
    Karino Y; Sugawara T; Saga A; Matsushima T; Miyazaki T
    Nihon Rinsho; 1988 Dec; 46(12):2715-9. PubMed ID: 2468003
    [No Abstract]   [Full Text] [Related]  

  • 8. (2'-5') Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections.
    Schattner A; Merlin G; Bregman V; Hahn T; Levin S; Revel M; Wallach D
    Clin Exp Immunol; 1984 Aug; 57(2):265-70. PubMed ID: 6467673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enzyme activity of interferon system in virus diseases].
    Sokolova TM; Suetina IA; Nosik NN; Krylov VF
    Biull Eksp Biol Med; 1991 May; 111(5):515-6. PubMed ID: 1715215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum 2-5 oligoadenylate synthetase activity in infectious diseases and collagen diseases in childhood].
    Arai T; Yamamoto H; Sakamoto M; Eda N; Matsumoto T; Ikei K; Hashimoto H; Seki T; Ohtani T; Ohishi T
    Kaku Igaku; 1991 Feb; 28(2):197-203. PubMed ID: 2051656
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical significance of 2-5 oligoadenylate synthetase analysis in blood cell chemical analysis].
    Kato Y; Hattori N
    Nihon Rinsho; 1989 Dec; 48 Suppl():963-6. PubMed ID: 2482910
    [No Abstract]   [Full Text] [Related]  

  • 12. Assay and the levels of 2-5A-synthetase in lymphocytes of patients with viral, bacterial and autoimmune diseases.
    Buffet-Janvresse C; Magard H; Robert N; Hovanessian AG
    Ann Immunol (Paris); 1983; 134D(2):247-58. PubMed ID: 6197930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome.
    Vojdani A; Lapp CW
    Immunopharmacol Immunotoxicol; 1999 May; 21(2):175-202. PubMed ID: 10319275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation of (2'-5') oligo A synthetase level in lymphocytes and granulocytes of patients with viral infections and leukemia.
    Schattner A; Wallach D; Merlin G; Hahn T; Levin S; Ramot B; Revel M
    J Interferon Res; 1982; 2(3):355-61. PubMed ID: 6182252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of serum 2'-5'-oligoadenylate synthetase for early diagnosis of viral infections among febrile adult patients.
    Yanai M; Gon Y; Suzuki K; Hayashi Y; Hasumi S; Otsuka H; Soma M
    Infect Dis (Lond); 2016; 48(5):338-42. PubMed ID: 26624960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interferon/2-5A synthetase system in primary preleukaemia patients.
    Justesen J; Hokland P; Hokland M
    Prog Clin Biol Res; 1985; 202():439-47. PubMed ID: 3868780
    [No Abstract]   [Full Text] [Related]  

  • 17. [2-5 oligoadenylate synthetase].
    Koura T; Kaneko S; Kobayashi K; Kato Y
    Nihon Rinsho; 1999 Sep; 57 Suppl():794-6. PubMed ID: 10543239
    [No Abstract]   [Full Text] [Related]  

  • 18. Study of 2'5' oligo (A) synthetase in patients with metastatic renal cell carcinoma.
    Vakalikos J; Dimasis N; Peftulidis S; Galaktidou G; Kortsaris AH
    Int J Biol Markers; 1995; 10(2):113-4. PubMed ID: 7561235
    [No Abstract]   [Full Text] [Related]  

  • 19. Enzyme markers for the presence of circulating interferon: 2-5A synthetase in blood lymphocytes and protein kinase in platelet-rich plasma.
    Buffet-Janvresse C; Hovanessian AG
    Proc Soc Exp Biol Med; 1984 Feb; 175(2):169-75. PubMed ID: 6198652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2'5' Oligoadenylate synthetase assay in human diseases. Its clinical value in viral liver diseases.
    Chousterman S; Chousterman M; Poitrine A; Chaput JC; Thang MN
    Prog Clin Biol Res; 1985; 202():431-8. PubMed ID: 3008173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.